PathologybioRxivPreprint
Interleukin-3 as a Potential Bone Anabolic Agent in treating Postmenopausal Osteoporosis
Vikrant Piprode, Shubhanath Behera, Juilee Karhade…·Mohan R. Wani
IL-3 treatment preserves trabecular bone architecture and enhances bone mineral density in ovariectomized mice, showing dual anti-osteoclastic and pro-osteoblastic effects in postmenopausal osteoporosis.
DOI 10.1101/2025.07.12.664485